**
Overview
Cystic fibrosis is a complex and multifaceted condition that affects approximately 70,000 people in the United States and over 80,000 worldwide. It is caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which codes for a protein responsible for regulating the movement of salt and water in and out of cells. In individuals with CF, the faulty CFTR protein leads to the production of thick, sticky mucus that clogs the airways, digestive tract, and other organs, causing a range of symptoms and complications.
Cystic fibrosis is often referred to as a "genetic disease" because it is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition. However, CF is not simply a matter of genetics; it is a complex interplay between genetic, environmental, and lifestyle factors that affect the course of the disease.
History/Background
The first recorded description of cystic fibrosis dates back to 1889, when British physician Hans von Ziemssen described a case of a child with a "fibrous" condition affecting the pancreas. However, it wasn't until the 1930s that the condition began to be recognized as a distinct medical entity. In the 1950s and 1960s, researchers began to identify the genetic basis of CF, and in 1989, the CFTR gene was cloned, paving the way for the development of genetic testing and targeted therapies.
Key Information
Cystic fibrosis is characterized by a range of symptoms, including:
* Respiratory problems: persistent cough, wheezing, shortness of breath, and recurrent lung infections
* Digestive issues: malabsorption of nutrients, abdominal pain, and bowel obstruction
* Reproductive problems: infertility, recurrent pregnancy loss, and increased risk of complications during pregnancy
* Other symptoms: salty sweat, sinus infections, and clubbing of the fingers and toes
The diagnosis of CF typically involves a combination of:
* Genetic testing: to identify the presence of the mutated CFTR gene
* Pulmonary function tests: to assess lung function and capacity
* Imaging studies: to evaluate the extent of lung damage and other complications
* Other tests: to rule out other conditions and monitor disease progression
Significance
Cystic fibrosis has a significant impact on individuals, families, and society as a whole. It is a leading cause of respiratory failure and death in children and young adults, and it places a significant burden on healthcare systems and families. However, advances in medical research and treatment have improved the quality of life and life expectancy for individuals with CF.
INFOBOX:
- Name: Cystic Fibrosis
- Type: Genetic disorder
- Date: 1889 (first recorded description)
- Location: Worldwide
- Known For: Development of targeted therapies and improved quality of life for individuals with CF
TAGS: cystic fibrosis, genetic disorder, respiratory disease, digestive disease, reproductive disease, CFTR gene, genetic testing, pulmonary function tests, imaging studies.
